RECTODERM 0.4% RECTAL OINTMENT 30g – 2026 Price Turkey

Clinical Data Review: Comprehensive profile for RECTODERM 0.4% RECTAL OINTMENT 30g, including its pharmacological composition, pricing in Turkey (2026), and regulatory status for international patients.

1. Pharmaceutical Profile

Proprietary Name: RECTODERM 0.4% RECTAL OINTMENT 30g

Manufacturer: GENVEON PHARMACEUTICAL INDUSTRY AND TRADE INC.

Registration Status: Licensed by T.C. Ministry of Health

Active Pharmaceutical Ingredient

GLISEROL TRINITRAT (NITROGLISERIN) 🔗

*Click to view bioequivalent formulations.

2. Therapeutic Indications

RECTODERM 0.4% RECTAL OINTMENT 30g is formulated with GLISEROL TRINITRAT (NITROGLISERIN), a clinically established agent in medical practice.

  • Mechanism of Action: GLISEROL TRINITRAT (NITROGLISERIN) acts according to the pharmacological principles of its drug class to provide therapeutic relief.
  • Primary Use: Prescribed by healthcare professionals for conditions responsive to GLISEROL TRINITRAT (NITROGLISERIN) therapy.
  • Dosage Regimen: Please refer to the official Patient Information Leaflet (PIL) included in the packaging for specific dosing instructions relative to age and severity of symptoms.

3. Market Data & Pricing (2026)

Note: Drug prices in Turkey are regulated under the Reference Pricing System (SUT) enforced by the government.

Product Name RECTODERM 0.4% RECTAL OINTMENT 30g
Barcode (GTIN) 8699293422846
Generic Name GLISEROL TRINITRAT (NITROGLISERIN)
License Holder GENVEON PHARMACEUTICAL INDUSTRY AND TRADE INC.
Pharmacy Retail Price 1237.35 TL
⚠️ Clinical Safety Warning

Do not administer RECTODERM 0.4% RECTAL OINTMENT 30g if the patient has a known hypersensitivity or allergy to GLISEROL TRINITRAT (NITROGLISERIN). Purchase only from authorized pharmacies (Eczane) to ensure supply chain integrity.


Disclaimer: This content is compiled from public pharmaceutical records for informational purposes. It does not constitute medical advice, diagnosis, or treatment. Always consult a qualified physician regarding any medical condition.
Data Source: Product label via GENVEON PHARMACEUTICAL INDUSTRY AND TRADE INC..

Leave a Comment